Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Biosenic Publishes New Data On Mechanism Of Action Of Arsenic Trioxide

March 30 (Reuters) - Bone Therapeutics SA  BIOS.BR :
    * BIOSENIC PUBLISHES NEW DATA ON MECHANISM OF ACTION OF
ARSENIC
TRIOXIDE (ATO)
    * ANNOUNCES THAT DATA PROVIDING ADDITIONAL DETAILS ABOUT
MECHANISM
OF ACTION OF ITS LEAD API ARSENIC TRIOXIDE (ATO) TO PREVENT
AUTOIMMUNE DISEASES HAS NOW BEEN PUBLISHED IN A PEER-REVIEWED
PAPER
    * ARTICLE ALSO DETAILS AN ORIGINAL ATO FORMULA TO MAXIMIZE
EFFICACY IN FIGHTING AUTOIMMUNITY AND REDUCING SIDE EFFECTS
    * NEW PEER-REVIEWED ARTICLE ALSO DEMONSTRATES THAT EFFICACY
OF ATO
IS PARTLY RELATED TO GENERATION OF REACTIVE OXYGEN SPECIES (ROS)

Source text for Eikon:  ID:nGNE86MgLP 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Biosenic SA

See all news